<DOC>
	<DOCNO>NCT01925651</DOCNO>
	<brief_summary>The aim study evaluate impact add bolus adjuvant radiotherapy mastectomy , relation time treatment interruption acute effect . This study evaluate whether increase treatment time addition bolus , overshadow benefit increase dose skin subcutaneous tissue .</brief_summary>
	<brief_title>Clinical Trial The Use Bolus Post Mastectomy Irradiation Breast Cancer</brief_title>
	<detailed_description>Rational : - The use high-energy photon ( 6 MeV ) create characteristic skin-sparing effect , generate region low-dose subcutaneous tissue . - The subcutaneous tissue possible area clinical failure chest wall mastectomy breast cancer . - To optimize treatment , use bio-equivalent material increase surface dose . - This dose increase may accompany great skin reaction , make necessary temporarily discontinue treatment recover radiodermatitis . - The total treatment time determinant tumor control treatment cancer radiation . Description : - This study aim evaluate whether different intensity application bolus correlate great likelihood treatment discontinuation . - This single blind randomise control trial . The target population comprise patient indication post mastectomy radiation ( PMRT ) . - The patient divide two group : one high risk recurrence subcutaneous , randomize use 0.5cm bolus every day consecutive day , one low-risk group , randomize use bolus 0.5cm alternate day use bolus . The group high risk define patient clinical pathological tumor invasion skin . The others consider low risk . - Randomization make group proportion patient high body mass index ( &gt; / = 30 kg/m2 ) , may factor worsen radiodermatitis . - The patient follow treatment evaluated weekly radiodermatitis , interruption time treatment recovery acute effect expenditures local care . The evaluation do blindly ( without knowledge utilization bolus ) train nurses management radiodermatitis .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Radiodermatitis</mesh_term>
	<criteria>Undergoing mastectomy without reconstruction early breast breast malignancy histologically proven Karnofsky Performance Scale ( KPS ) &lt; 70 % Start treatment &lt; 10 day follow chemotherapy / surgery Concomitant chemotherapy ( permitted hormone therapy moleculartargeted ) Prior ipsilateral thoracic / cervical irradiation Proven metastatic disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Post Mastectomy Radiotherapy</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Bolus</keyword>
	<keyword>Radiodermatitis</keyword>
</DOC>